نتایج جستجو برای: hepatic amyloidosis

تعداد نتایج: 104741  

2016
James S. Butler Amy Chan Susete Costelha Shannon Fishman Jennifer L. S. Willoughby Todd D. Borland Stuart Milstein Donald J. Foster Paula Gonçalves Qingmin Chen June Qin Brian R. Bettencourt Dinah W. Sah Rene Alvarez Kallanthottathil G. Rajeev Muthiah Manoharan Kevin Fitzgerald Rachel E. Meyers Saraswathy V. Nochur Maria J. Saraiva Tracy S. Zimmermann

ATTR amyloidosis is a systemic, debilitating and fatal disease caused by transthyretin (TTR) amyloid accumulation. RNA interference (RNAi) is a clinically validated technology that may be a promising approach to the treatment of ATTR amyloidosis. The vast majority of TTR, the soluble precursor of TTR amyloid, is expressed and synthesized in the liver. RNAi technology enables robust hepatic gene...

Journal: :Journal of Korean Medical Science 1988

Journal: :Journal of Medical Sciences and Health 2020

Journal: :Medical Journal of Dr. D.Y. Patil Vidyapeeth 2021

Journal: :European review for medical and pharmacological sciences 2000
G Basile D Villari V Nicita-Mauro

Primary systemic amyloidosis (AL) is an uncommon disease characterized by the extracellular deposition of a protein with a beta-fibrillar structure, consisting of monoclonal immunoglobulin light chains, lambda or kappa (ratio of lambda to kappa, 3:1). In systemic amyloidosis liver involvement is frequent but it rarely has clinical importance. The massive and localized liver deposition of amyloi...

2016
Ufuk Ilgen Zeynep Kendi Celebi Gulsah Kaygusuz Sim Kutlay Gokhan Nergizoglu Kenan Ates

Liver is one of the most commonly involved organs in both primary and secondary systemic amyloidoses, but hepatic amyloidosis, manifested as mild to moderate enlargement, is usually not symptomatic nor it is clinically problematic. Rarely, massive hepatomegaly, severe cholestatic hepatitis or liver failure may be encountered in patients with systemic amyloidosis. Two cases with lambda light-cha...

Journal: :Internal medicine 2018
Kazuya Ishiguro Toshiaki Hayashi Yoshihiro Yokoyama Yuka Aoki Kei Onodera Hiroshi Ikeda Tadao Ishida Hiroshi Nakase

Objective The complication of systemic immunoglobulin light chain (AL) amyloidosis in patients with monoclonal immunoglobulin affects the prognosis, but amyloid deposition in tissues is sometimes difficult to detect due to bleeding tendencies and preferential distributions. However, fibrinolysis is known to be exacerbated in patients with systemic AL amyloidosis specifically. We therefore explo...

Journal: :Postgraduate medical journal 1982
J A Amado R Ondiviela S Palacios D Casanova J Manzanos J Freijanes

Introduction Systemic amyloidosis is often associated with microscopic deposits in the thyroid gland (Kennedy, Thompson and Buchanan, 1974). Far less frequently the amyloid deposits are large enough to become palpable. When this occurs, there is usually clinical or biochemical evidence of hepatic or renal involvement (Kennedy et al., 1974). A case is reported in which the initial manifestation ...

Journal: :Journal of comparative pathology 2009
H Hatai K Ochiai S Nakamura T Kamiya M Ito H Yamamoto Y Sunden T Umemura

An adult swan goose (Anser cygnoides) kept in a zoological garden had gross hepatic enlargement with extensive ill-defined white foci. Microscopically, the hepatic lesions were composed of a mixture of adipocytes and myeloid cells. The goose was also affected with systemic amyloidosis and there were areas of osseous metaplasia associated with deposition of amyloid within the liver.

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید